Clinical Trial Update: A Study to Evaluate the Use of Placenta Protein 13 (PP13) in the First Trimester of Pregnancy as a Diagnostic Aiding Tool in the Assessment of the Risk for Developing Preeclampsia in Women With Low and Unknown Risk

View source ↗

Summary

A completed study evaluated placenta protein 13 (PP13) in the first trimester as a diagnostic aid to assess the risk of developing preeclampsia in women with lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Snippet

Sponsor: Carl Weiner, MD | Conditions: Preeclampsia | Status: COMPLETED